An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...
Please provide your email address to receive an email when new articles are posted on . Successful treatment of anaphylaxis symptoms with a single dose of neffy 2 mg was found in 89.2% of patients in ...
Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...
Please provide your email address to receive an email when new articles are posted on . Overall, 86% of physicians felt that patients would prefer needle-free epinephrine. Patient confidence in dosing ...
Canada for adults and children (>30 kg) living with severe allergic reactions ALK- Abelló A/S, which licenses the rights to market neffy in Canada, expects availability in the summer of 2026 SAN DIEGO ...
TORONTO - Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray ...
The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results